Entrada Therapeutics, Inc. (TRDA)

Entrada Therapeutics Revenue

Entrada Therapeutics had revenue of $1.95M in the quarter ending June 30, 2025, a decrease of -97.94%. This brings the company's revenue in the last twelve months to $79.48M, down -66.80% year-over-year. In the year 2024, Entrada Therapeutics had annual revenue of $210.78M with 63.38% growth.

• Revenue (ttm): $79.48M
• Revenue Growth: -66.80%
• P/S Ratio: 3.77
• Revenue / Employee: $434,295
• Employees: 183
• Market Cap: 260.96M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	210.78M	81.77M	63.38%
Dec 31, 2023	129.01M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-